Early Intervention With Tiotropium (Spiriva) in Chinese Patients With Chronic Obstructive Pulmonary Disease (COPD): a Randomized, Double-blind, Placebo-controlled, Parallel, Multicentre Trial.
Phase of Trial: Phase IV
Latest Information Update: 07 Sep 2017
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms Tie-COPD
- 07 Sep 2017 Primary endpoint (difference of trough FEV1 at 24 months from baseline) has been met as per results published in the New England Journal of Medicine
- 07 Sep 2017 Results published in the New England Journal of Medicine
- 10 Aug 2016 Status changed from active, no longer recruiting to completed.